Maharashtra has seen a surge in suspected Guillain-Barre Syndrome (GBS) cases to 170, with 132 confirmed. Out of these, 5 ...
Q4 2024 Management View CEO Soren Tulstrup highlighted full-year 2024 revenue of SEK 171.3 million, marking a 28% year-over-year increase, with IDEFIRIX product sales contributing SEK 140.1 million ...